EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of Intravenous Iron Substitution on Serum Phosphate Levels and Bone Turnover Markers—An Open-Label Pilot Study

Alexandra Struppe, Jakob E Schanda, Andreas Baierl, Paul Watzl, Christian Muschitz iD

Nutrients · 2023

DOI: 10.3390/nu15122693 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2023. Verfasst von Alexandra Struppe und 4 weiteren Autor:innen. Beteiligte Einrichtung: St. Vincent Hospital Vienna, II Medical Department-Gastroenterology, Hepatology, Metabolic, and Inflammation Medicine, Academic Teaching Hospital of …. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Hypophosphatemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The association between intravenous iron substitution therapy and hypophosphatemia was previously reported in patients with iron deficiency anemia. However, the extent of hypophosphatemia is thought to depend on the type of iron supplementation. We hypothesized that the intravenous application of ferric carboxymaltose and iron sucrose leads to a different longitudinal adaptation in serum phosphate levels. In this open-label pilot study, a total of 20 patients with inflammatory bowel diseases or iron deficiency anemia were randomly assigned to one of two study groups (group 1: ferric carboxymaltose, n = 10; group 2: iron sucrose, n = 10). Serum values were controlled before iron substitution therapy, as well as 2, 4, and 12 weeks after the last drug administration. The primary objective of the study was the longitudinal evaluation of serum phosphate levels after iron substitution therapy with ferric carboxymaltose and iron sucrose. The secondary objective was the longitudinal investigation of calcium, 25-hydroxyvitamin D (25(OH)D), intact parathyroid hormone, procollagen type 1 amino-terminal propeptide (P1NP), beta-CrossLaps (CTX), hemoglobin (Hb), iron, ferritin, and transferrin saturation levels. Two weeks after drug administration, phosphate levels were significantly lower (p < 0.001) in group 1 and ferritin levels were significantly higher (p < 0.001) in group 1. Phosphate levels (0.8–1.45 mmol/L) were below the therapeutic threshold and ferritin levels (10–200 ng/mL for women and 30–300 ng/mL for men) were above the therapeutic threshold in group 1. P1NP (15–59 µg/L) and CTX (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Iron-DeficiencyHypophosphatemiaMaleHumansFemaleIronFerric Oxide, SaccharatedPilot ProjectsFerric CompoundsFerritinsPhosphatesHemoglobinsBone RemodelingMaltose

Stichwörter der Autor:innen

25-hydroxyvitamin D (25(OH)D)beta-CrossLaps (CTX)bone turnover markersferric carboxymaltosehypophosphatemiairon substitution therapyiron sucrosephosphateprocollagen type 1 amino-terminal propeptide (P1NP)

Substanzen

IronFerric Oxide, SaccharatedFerric CompoundsFerritinsPhosphatesHemoglobinsferric carboxymaltoseMaltose

Autor:innen und Institutionen

  • St. Vincent Hospital Vienna, II Medical Department-Gastroenterology, Hepatology, Metabolic, and Inflammation Medicine, Academic Teaching Hospital of the Medical University of Vienna, 1060 Vienna, Austria.
  • AUVA Trauma Center Vienna-Meidling, Department for Trauma Surgery, 1120 Vienna, Austria.
  • Ludwig Boltzmann Institute for Traumatology, 1200 Vienna, Austria.
  • Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
  • Insitute for Statistics and Operations Research, University of Vienna, 1090 Vienna, Austria.
  • HealthPi Medical Center, 1010 Vienna, Austria.

ORCID-Profile: Christian Muschitz

Zitieren

APA

Struppe, A., Schanda, J. E., Baierl, A., Watzl, P., & Muschitz, C. (2023). Impact of Intravenous Iron Substitution on Serum Phosphate Levels and Bone Turnover Markers—An Open-Label Pilot Study. Nutrients. https://doi.org/10.3390/nu15122693

Vancouver

Struppe A, Schanda JE, Baierl A, Watzl P, Muschitz C. Impact of Intravenous Iron Substitution on Serum Phosphate Levels and Bone Turnover Markers—An Open-Label Pilot Study. Nutrients. 2023. doi:10.3390/nu15122693

BibTeX
@article{Struppe2023,
  author = {Struppe, Alexandra and Schanda, Jakob E and Baierl, Andreas and Watzl, Paul and Muschitz, Christian},
  title = {Impact of Intravenous Iron Substitution on Serum Phosphate Levels and Bone Turnover Markers—An Open-Label Pilot Study},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15122693}
}
Kostenlos starten →